MedTrace Logo

Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents

NCT01686607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40110

Last updated 2024-10-21

No results posted yet for this study

Summary

This multicenter observational cohort study proposes to establish the risks of short and long-term outcomes in users of parenteral micafungin and in users of other parenteral antifungal agents from 2005 through 2012 with follow-up until 2017.

Conditions

  • Systemic Fungal Infections

Interventions

DRUG

Parenteral micafungin application

Parenteral

DRUG

Other parenteral antifungal drugs

Parenteral

Sponsors & Collaborators

  • World Health Information Science Consultants, LLC

    collaborator OTHER

  • Astellas Pharma Europe B.V.

    lead INDUSTRY

Principal Investigators

  • Lead Investigator · WHISCON, LLC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-01
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01686607 on ClinicalTrials.gov